Showing 1 - 9 results of 9 for search 'Jan-Willem C. Alffenaar', query time: 0.09s Refine Results
  1. 1
    Pharmacokinetics and pharmacodynamics of anti-tuberculosis drugs: An evaluation of in vitro, in vivo methodologies and human studies

    Pharmacokinetics and pharmacodynamics of anti-tuberculosis drugs: An evaluation of in vitro, in vivo methodologies and human studies by Jan-Willem C. Alffenaar, Jan-Willem C. Alffenaar, Jan-Willem C. Alffenaar, Jurriaan E. M. de Steenwinkel, Andreas H. Diacon, Ulrika S. H. Simonsson, Shashikant Srivastava, Sebastian G. Wicha

    Published 2022
    Connect to this object online.
    Book
    Save to List
    Saved in:
  2. 2
    Barriers to Optimal Tuberculosis Treatment Services at Community Health Centers: A Qualitative Study From a High Prevalent Tuberculosis Country

    Barriers to Optimal Tuberculosis Treatment Services at Community Health Centers: A Qualitative Study From a High Prevalent Tuberculosis Country by Ivan S. Pradipta, Ivan S. Pradipta, Lusiana R. Idrus, Lusiana R. Idrus, Ari Probandari, Ari Probandari, Irma Melyani Puspitasari, Irma Melyani Puspitasari, Prayudi Santoso, Jan-Willem C. Alffenaar, Jan-Willem C. Alffenaar, Jan-Willem C. Alffenaar, Jan-Willem C. Alffenaar, Eelko Hak

    Published 2022
    Connect to this object online.
    Book
    Save to List
    Saved in:
  3. 3
    Pharmacokinetic Drug Interactions of Antimicrobial Drugs: A Systematic Review on Oxazolidinones, Rifamycines, Macrolides, Fluoroquinolones, and Beta-Lactams

    Pharmacokinetic Drug Interactions of Antimicrobial Drugs: A Systematic Review on Oxazolidinones, Rifamycines, Macrolides, Fluoroquinolones, and Beta-Lactams by Jan-Willem C. Alffenaar, Arianna D. Pranger, Mathieu S. Bolhuis, Jos G. W. Kosterink, Prashant N. Panday

    Published 2011
    Connect to this object online.
    Book
    Save to List
    Saved in:
  4. 4
    Therapeutic Drug Monitoring and Biomarkers; towards Better Dosing of Antimicrobial Therapy

    Therapeutic Drug Monitoring and Biomarkers; towards Better Dosing of Antimicrobial Therapy by Eman Wehbe, Asad E. Patanwala, Christine Y. Lu, Hannah Yejin Kim, Sophie L. Stocker, Jan-Willem C. Alffenaar

    Published 2024
    Connect to this object online.
    Book
    Save to List
    Saved in:
  5. 5
    Barriers and strategies to successful tuberculosis treatment in a high-burden tuberculosis setting: a qualitative study from the patient's perspective

    Barriers and strategies to successful tuberculosis treatment in a high-burden tuberculosis setting: a qualitative study from the patient's perspective by Ivan S. Pradipta, Lusiana R. Idrus, Ari Probandari, Bony W. Lestari, Ajeng Diantini, Jan-Willem C. Alffenaar, Eelko Hak

    Published 2021
    Connect to this object online.
    Book
    Save to List
    Saved in:
  6. 6
    Dried Blood Spot Sampling to Assess Rifampicin Exposure and Treatment Outcomes among Native and Non-Native Tuberculosis Patients in Paraguay: An Exploratory Study

    Dried Blood Spot Sampling to Assess Rifampicin Exposure and Treatment Outcomes among Native and Non-Native Tuberculosis Patients in Paraguay: An Exploratory Study by Samiksha Ghimire, Gladys Molinas, Arturo Battaglia, Nilza Martinez, Luis Gómez Paciello, Sarita Aguirre, Jan-Willem C. Alffenaar, Marieke G. G. Sturkenboom, Cecile Magis-Escurra

    Published 2023
    Connect to this object online.
    Book
    Save to List
    Saved in:
  7. 7
    Inflammation altered correlation between CYP2C19 genotype and CYP2C19 activity in patients receiving voriconazole

    Inflammation altered correlation between CYP2C19 genotype and CYP2C19 activity in patients receiving voriconazole by Sylvia D. Klomp, Anette Veringa, Jan‐Willem C. Alffenaar, Mark G. J. deBoer, Lambert F. R. Span, Henk‐Jan Guchelaar, Jesse J. Swen

    Published 2024
    Connect to this object online.
    Book
    Save to List
    Saved in:
  8. 8
    Drug Exposure and Susceptibility of Pyrazinamide Correlate with Treatment Response in Pyrazinamide-Susceptible Patients with Multidrug-Resistant Tuberculosis

    Drug Exposure and Susceptibility of Pyrazinamide Correlate with Treatment Response in Pyrazinamide-Susceptible Patients with Multidrug-Resistant Tuberculosis by Shulan Dong, Ge Shao, Lina Davies Forsman, Sainan Wang, Shanshan Wang, Jiayi Cao, Ziwei Bao, Judith Bruchfeld, Jan-Willem C. Alffenaar, Jia Liu, Yi Hu, Meiying Wu

    Published 2024
    Connect to this object online.
    Book
    Save to List
    Saved in:
  9. 9
    Safety of Rifampicin at High Dose for Difficult-to-Treat Tuberculosis: Protocol for RIAlta Phase 2b/c Trial

    Safety of Rifampicin at High Dose for Difficult-to-Treat Tuberculosis: Protocol for RIAlta Phase 2b/c Trial by Juan Espinosa-Pereiro, Samiksha Ghimire, Marieke G. G. Sturkenboom, Jan-Willem C. Alffenaar, Margarida Tavares, Sarita Aguirre, Arturo Battaglia, Gladys Molinas, Teresa Tórtola, Onno W. Akkerman, Adrian Sanchez-Montalva, Cecile Magis-Escurra

    Published 2022
    Connect to this object online.
    Book
    Save to List
    Saved in:

Search Tools: